P3 Health Partners (PIII) Receivables - Other (2020 - 2023)

P3 Health Partners has reported Receivables - Other for 3 years, with the latest figure at $4.6 million in Q1 2023.

• For the quarter ending Q1 2023, Receivables - Other rose 689.34% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2023 stood at $4.6 million (up 689.34% YoY), and the FY2022 full-year result was $177000.0, changed N/A from the prior year.
• Receivables - Other for Q1 2023 stood at $4.6 million, down from $6.7 million in the prior quarter.
• The five-year high for Receivables - Other was $6.7 million in Q4 2022, with the low at $146117.0 in Q4 2020.
• Historically, Receivables - Other has averaged $2.5 million across 3 years, with a median of $1.7 million in 2022.
• The largest YoY upside for Receivables - Other was 689.34% in 2023 against a maximum downside of 689.34% in 2023.
• P3 Health Partners' Receivables - Other stood at $146117.0 in 2020, then surged by 4470.31% to $6.7 million in 2022, then plunged by 30.52% to $4.6 million in 2023.
• The last three Receivables - Other figures came in at $4.6 million (Q1 2023), $6.7 million (Q4 2022), and $2.7 million (Q3 2022), per Business Quant data.